Adriana Casallas‐Vanegas

Cyclophosphamide treatment in active multiple sclerosis

Enrique Gómez‐Figueroa, Efrain Gutierrez-Lanz, Alonso Alvarado‐Bolaños et al. · Neurological Sciences · 2021 · 26 citations

Neurological Disorder, Pharmacotherapy, Neurology +5

Socioeconomic status and access to multiple sclerosis treatment in Mexico

Enrique Gómez‐Figueroa, Adib Jorge de Saráchaga, Christian García‐Estrada et al. · Multiple Sclerosis and Related Disorders · 2021 · 15 citations

Health Care Disparity, Health Policy, Health Inequity +6

Severe fingolimod rebound syndrome after switching to cladribine treatment

Fernanda Coss-Rovirosa, Jorge Carlos Salado-Burbano, Adriana Casallas‐Vanegas et al. · Multiple Sclerosis and Related Disorders · 2020 · 12 citations

Rebound Effect, Surgery

Rituximab as an effective therapeutic option in refractory Neuro-Behçet syndrome

Christian García‐Estrada, Adriana Casallas‐Vanegas, Indhira Zabala‐Ángeles et al. · Journal of Neuroimmunology · 2020 · 12 citations

Neurobiology Of Disease, Autoimmune Disease, Medicine +7

Rituximab efficacy at different initial and maintenance doses in neuromyelitis optica spectrum disorder: Experience from a national health institute in México

Adriana Casallas‐Vanegas, Enrique Gómez‐Figueroa, Adib Jorge de Saráchaga et al. · Journal of the Neurological Sciences · 2020 · 10 citations